39001565	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
Chest	O	O
CT	O	O
,	O	O
08/04/2009	O	O
Clinical	O	O
History	O	O
:	O	O
Colon	O	O
cancer	O	O
.	O	O
Technique	O	O
:	O	O
A	O	O
2.5	O	O
mm	O	O
spiral	O	O
CT	O	O
was	O	O
performed	O	O
from	O	O
the	O	O
lung	O	O
apices	O	O
to	O	O
the	O	O
bases	O	O
utilizing	O	O
intravenous	O	O
contrast	O	O
.	O	O
Findings	O	O
:	O	O
No	O	O
lung	O	O
nodules	O	O
suspicious	O	O
for	O	O
metastatic	O	O
disease	O	O
is	O	O
definitely	O	O
seen	O	O
.	O	O
Dependent	O	O
atelectasis	O	O
is	O	O
noted	O	O
.	O	O
There	O	O
is	O	O
scarring	O	O
in	O	O
the	O	O
lung	O	O
apices	O	O
.	O	O
There	O	O
appears	O	O
to	O	O
be	O	O
granulomatous	O	O
disease	O	O
.	O	O
The	O	O
kyphosis	O	O
is	O	O
noted	O	O
.	O	O
There	O	O
appear	O	O
to	O	O
be	O	O
stable	O	3_Yellow_Days
compression	3_Yellow_Days	3_Yellow_Days
fractures	3_Yellow_Days	3_Yellow_Days
of	3_Yellow_Days	3_Yellow_Days
the	3_Yellow_Days	3_Yellow_Days
spine	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	3_Yellow_Days
there	3_Yellow_Days	O
appears	3_Yellow_Days	O
to	3_Yellow_Days	3_Yellow_Days
be	3_Yellow_Days	3_Yellow_Days
osteopenia	3_Yellow_Days	3_Yellow_Days
.	O	O
The	O	O
esophagus	3_Yellow_Days	O
is	O	O
again	O	O
noted	O	O
to	O	O
be	O	O
patulous	O	3_Yellow_Days
and	O	3_Yellow_Days
has	O	3_Yellow_Days
an	O	3_Yellow_Days
air	3_Yellow_Days	3_Yellow_Days
fluid	3_Yellow_Days	3_Yellow_Days
level	3_Yellow_Days	3_Yellow_Days
within	3_Yellow_Days	3_Yellow_Days
it	3_Yellow_Days	O
.	O	O
Clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
for	3_Yellow_Days	O
dysphagia	3_Yellow_Days	O
is	3_Yellow_Days	O
suggested	3_Yellow_Days	O
.	O	O
No	O	O
esophageal	O	O
mass	O	O
is	O	O
definitely	O	O
seen	O	O
.	O	O
Low	3_Yellow_Days	O
attenuation	3_Yellow_Days	O
lesions	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
thyroid	3_Yellow_Days	O
gland	3_Yellow_Days	O
are	3_Yellow_Days	O
again	3_Yellow_Days	O
noted	3_Yellow_Days	O
and	3_Yellow_Days	O
again	3_Yellow_Days	O
suggest	3_Yellow_Days	O
goiter	3_Yellow_Days	O
;	3_Yellow_Days	O
clinical	3_Yellow_Days	O
correlation	3_Yellow_Days	O
suggested	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
mild	O	O
degenerative	O	O
changes	O	O
of	O	O
both	O	O
shoulders	O	O
and	O	O
moderate	O	O
degenerative	O	O
change	O	O
of	O	O
the	O	O
spine	O	O
.	O	O
Old	O	O
left	O	O
rib	O	O
fractures	O	O
are	O	O
again	O	O
appreciated	O	O
.	O	O
Please	O	O
see	O	O
the	O	O
abdomen	O	O
CT	O	O
report	O	O
of	O	O
the	O	O
same	O	O
day	O	O
for	O	O
findings	O	O
in	O	O
the	O	O
abdomen	O	O
.	O	O
IMPRESSION	O	O
:	O	O
No	O	O
definite	O	O
evidence	O	O
of	O	O
metastatic	O	O
disease	O	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
MCW	O	O
1820231	O	O
HEMOPTYSIS	O	O
,	O	O
H/O	O	O
RUL	O	O
LESION	O	O
,	O	O
BREAST	O	O
CA	O	O
HISTORY	O	O
OF	O	O
MYELODYSPLASTIC	O	O
DISEASE	O	O
CT	O	O
THORAX	O	O
,	O	O
CT	O	O
LIVER/SPLEEN	O	O
&	O	O
CT	O	O
PELVIS	O	O
-LRB-	O	O
#	O	O
452A	O	O
,	O	O
450A	O	O
&	O	O
451A	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
2.5	O	O
MM	O	O
AXIAL	O	O
COMPUTED	O	O
TOMOGRAPHIC	O	O
IMAGES	O	O
WERE	O	O
OBTAINED	O	O
THROUGH	O	O
THE	O	O
CHEST	O	O
,	O	O
ABDOMEN	O	O
AND	O	O
PELVIS	O	O
AFTER	O	O
THE	O	O
ADMINISTRATION	O	O
OF	O	O
ORAL	O	O
AND	O	O
131	O	O
CC	O	O
OF	O	O
INTRAVENOUS	O	O
OMNIPAQUE	O	O
300	O	O
.	O	O
COMPARISON	O	O
:	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
FINDINGS	O	O
:	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
AN	O	O
ANTERIOR	1_Red_Minutes	1_Red_Minutes
SEGMENT	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
MASS	1_Red_Minutes	1_Red_Minutes
IS	1_Red_Minutes	O
IDENTIFIED	1_Red_Minutes	O
AT	1_Red_Minutes	O
THE	1_Red_Minutes	O
JUNCTION	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
SUPERIOR	1_Red_Minutes	1_Red_Minutes
VENA	1_Red_Minutes	1_Red_Minutes
CAVA	1_Red_Minutes	1_Red_Minutes
AND	1_Red_Minutes	1_Red_Minutes
LEFT	1_Red_Minutes	1_Red_Minutes
INNOMINATE	1_Red_Minutes	1_Red_Minutes
VEIN	1_Red_Minutes	1_Red_Minutes
.	O	O
IT	1_Red_Minutes	O
MEASURES	1_Red_Minutes	1_Red_Minutes
3.6	1_Red_Minutes	1_Red_Minutes
CM	1_Red_Minutes	1_Red_Minutes
X	1_Red_Minutes	1_Red_Minutes
2.2	1_Red_Minutes	1_Red_Minutes
CM	1_Red_Minutes	1_Red_Minutes
IN	O	O
DIMENSION	O	O
.	O	O
COMPARED	O	O
TO	O	O
A	O	O
SIMILAR	O	O
LOCATION	O	O
,	O	O
THIS	1_Red_Minutes	1_Red_Minutes
MASS	1_Red_Minutes	1_Red_Minutes
MEASURED	1_Red_Minutes	O
3.9	1_Red_Minutes	1_Red_Minutes
MM	1_Red_Minutes	1_Red_Minutes
X	1_Red_Minutes	1_Red_Minutes
2.6	1_Red_Minutes	3_Yellow_Days
MM	1_Red_Minutes	3_Yellow_Days
IN	O	O
DIMENSION	O	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
PRIOR	1_Red_Minutes	O
EXAM	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
LARGE	1_Red_Minutes	3_Yellow_Days
CENTRAL	1_Red_Minutes	3_Yellow_Days
HYPOATTENUATING	1_Red_Minutes	3_Yellow_Days
COMPONENT	1_Red_Minutes	3_Yellow_Days
SUGGESTING	1_Red_Minutes	3_Yellow_Days
NECROSIS	1_Red_Minutes	3_Yellow_Days
WHICH	1_Red_Minutes	3_Yellow_Days
HAS	1_Red_Minutes	3_Yellow_Days
INCREASED	1_Red_Minutes	3_Yellow_Days
IN	O	3_Yellow_Days
COMPARISON	O	3_Yellow_Days
TO	O	3_Yellow_Days
THE	O	3_Yellow_Days
PRIOR	O	3_Yellow_Days
EXAMINATION	O	3_Yellow_Days
.	O	O
THERE	O	O
IS	O	O
PERIPHERAL	1_Red_Minutes	O
ENHANCEMENT	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
ADJACENT	O	O
MINIMAL	3_Yellow_Days	1_Red_Minutes
ATELECTASIS	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
ANTERIOR	3_Yellow_Days	1_Red_Minutes
RIGHT	3_Yellow_Days	1_Red_Minutes
UPPER	3_Yellow_Days	1_Red_Minutes
LOBE	3_Yellow_Days	1_Red_Minutes
.	O	O
OTHERWISE	O	O
,	O	O
NO	O	O
ADDITIONAL	O	O
PULMONARY	O	O
NODULES	O	O
ARE	O	O
IDENTIFIED	O	O
.	O	O
THERE	O	O
IS	O	O
MOTION	O	O
ARTIFACT	O	O
,	O	O
ESPECIALLY	O	O
AT	O	O
THE	O	O
LUNG	O	O
BASES	O	O
.	O	O
NO	O	O
MEDIASTINAL	O	O
,	O	O
HILAR	O	O
OR	O	O
AXILLARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THE	O	O
PATIENT	O	O
HAS	O	O
HAD	O	O
BILATERAL	O	O
MASTECTOMIES	O	O
.	O	O
NO	O	O
INTERNAL	O	O
MAMMARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THERE	O	O
ARE	O	O
SUBTLE	3_Yellow_Days	1_Red_Minutes
AREAS	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
LOW	3_Yellow_Days	1_Red_Minutes
ATTENUATION	3_Yellow_Days	3_Yellow_Days
WITHIN	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
THYROID	3_Yellow_Days	3_Yellow_Days
GLAND	3_Yellow_Days	3_Yellow_Days
,	O	3_Yellow_Days
WHICH	O	3_Yellow_Days
MAY	O	3_Yellow_Days
REPRESENT	O	3_Yellow_Days
SMALL	O	3_Yellow_Days
NODULES	O	3_Yellow_Days
.	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
AGAIN	O	O
IDENTIFIED	O	O
IS	O	O
A	3_Yellow_Days	O
PLEURAL	3_Yellow_Days	O
-	3_Yellow_Days	O
BASED	3_Yellow_Days	O
LINEAR	3_Yellow_Days	O
AREA	3_Yellow_Days	O
OF	3_Yellow_Days	O
THICKENING	3_Yellow_Days	3_Yellow_Days
MEASURING	3_Yellow_Days	O
APPROXIMATELY	3_Yellow_Days	O
5	3_Yellow_Days	O
MM	3_Yellow_Days	3_Yellow_Days
IN	O	3_Yellow_Days
SIZE	O	3_Yellow_Days
IN	O	3_Yellow_Days
THE	O	3_Yellow_Days
LEFT	3_Yellow_Days	3_Yellow_Days
APEX	3_Yellow_Days	3_Yellow_Days
,	O	3_Yellow_Days
WHICH	O	3_Yellow_Days
REMAINS	O	3_Yellow_Days
UNCHANGED	O	3_Yellow_Days
.	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
EVALUATION	O	O
OF	O	O
THE	O	O
LIVER	3_Yellow_Days	O
AGAIN	O	O
DEMONSTRATES	O	O
A	O	O
2.3	3_Yellow_Days	1_Red_Minutes
CM	3_Yellow_Days	1_Red_Minutes
X	3_Yellow_Days	1_Red_Minutes
1.7	3_Yellow_Days	1_Red_Minutes
CM	3_Yellow_Days	1_Red_Minutes
LOW-ATTENUATION	3_Yellow_Days	1_Red_Minutes
LESION	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
SEGMENT	3_Yellow_Days	1_Red_Minutes
2	3_Yellow_Days	O
,	O	O
WHICH	O	O
TAKEN	O	O
INTO	O	O
ACCOUNT	O	O
DIFFERENCES	O	O
IN	O	O
TECHNIQUE	O	O
,	O	O
DEMONSTRATES	3_Yellow_Days	O
NO	3_Yellow_Days	O
SIGNIFICANT	3_Yellow_Days	O
INTERVAL	3_Yellow_Days	O
CHANGE	3_Yellow_Days	O
.	O	O
ALSO	O	O
IDENTIFIED	O	O
IS	O	O
A	O	O
LOW-ATTENUATION	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
SEGMENT	3_Yellow_Days	3_Yellow_Days
3	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
LIVER	3_Yellow_Days	O
MEASURING	3_Yellow_Days	O
APPROXIMATELY	3_Yellow_Days	O
15	3_Yellow_Days	O
MM	3_Yellow_Days	O
IN	3_Yellow_Days	O
SIZE	3_Yellow_Days	O
,	O	O
WHICH	O	O
DEMONSTRATES	O	O
NO	O	O
SIGNIFICANT	O	O
INTERVAL	O	O
CHANGE	O	O
.	O	O
BOTH	3_Yellow_Days	O
THESE	3_Yellow_Days	O
LESIONS	3_Yellow_Days	O
ARE	3_Yellow_Days	O
PRESUMED	3_Yellow_Days	O
TO	3_Yellow_Days	O
BE	3_Yellow_Days	O
HEPATIC	3_Yellow_Days	O
CYSTS	3_Yellow_Days	O
.	O	O
A	O	O
SMALLER	3_Yellow_Days	O
LOW-ATTENUATION	3_Yellow_Days	O
LESION	3_Yellow_Days	O
IS	3_Yellow_Days	O
IDENTIFIED	3_Yellow_Days	O
NEAR	3_Yellow_Days	O
THE	3_Yellow_Days	O
DOME	3_Yellow_Days	O
,	3_Yellow_Days	O
WHICH	3_Yellow_Days	O
IS	3_Yellow_Days	3_Yellow_Days
TOO	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
TO	3_Yellow_Days	3_Yellow_Days
CHARACTERIZE	3_Yellow_Days	3_Yellow_Days
SEEN	O	O
ON	O	O
IMAGE	O	O
#	O	O
85	O	O
,	O	O
SERIES	O	O
3	O	O
,	O	O
WHICH	O	3_Yellow_Days
MAY	O	3_Yellow_Days
ALSO	O	3_Yellow_Days
REPRESENT	O	3_Yellow_Days
A	O	3_Yellow_Days
SMALL	O	3_Yellow_Days
CYST	O	3_Yellow_Days
.	O	O
NO	3_Yellow_Days	O
NEW	3_Yellow_Days	O
HEPATIC	3_Yellow_Days	O
LESIONS	3_Yellow_Days	O
ARE	O	O
SEEN	O	O
.	O	O
WITHIN	O	O
THE	O	O
SPLEEN	3_Yellow_Days	O
,	O	O
THERE	O	O
IS	O	O
A	O	O
SUBTLE	3_Yellow_Days	O
AREA	3_Yellow_Days	O
OF	3_Yellow_Days	O
LOW-ATTENUATION	3_Yellow_Days	O
SEEN	O	O
ON	O	O
A	O	O
PRIOR	O	O
ABDOMEN/PELVIS	O	O
CT	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
WITHIN	O	O
THE	O	O
SPLEEN	O	O
,	O	O
WHICH	O	O
AGAIN	O	O
MOST	3_Yellow_Days	O
LIKELY	3_Yellow_Days	O
REPRESENTS	3_Yellow_Days	O
A	3_Yellow_Days	O
SMALL	3_Yellow_Days	1_Red_Minutes
HEMANGIOMA	3_Yellow_Days	1_Red_Minutes
AND	O	1_Red_Minutes
MEASURES	3_Yellow_Days	O
APPROXIMATELY	3_Yellow_Days	O
2.7	3_Yellow_Days	3_Yellow_Days
MM	3_Yellow_Days	3_Yellow_Days
IN	O	3_Yellow_Days
SIZE	O	3_Yellow_Days
.	O	O
OTHERWISE	O	O
,	O	O
THE	O	O
SPLEEN	O	O
IS	O	O
UNREMARKABLE	O	O
.	O	O
THE	O	O
BILATERAL	O	O
ADRENAL	O	O
GLANDS	O	O
AND	O	O
KIDNEYS	O	O
ARE	O	O
OTHERWISE	O	O
UNREMARKABLE	O	O
.	O	O
AN	O	O
EXTRARENAL	O	O
PELVIS	O	O
IS	O	O
SEEN	O	O
ON	O	O
THE	O	O
RIGHT	O	O
.	O	O
INCIDENTALLY	O	O
NOTED	O	O
,	O	O
IS	O	O
A	O	O
RETROAORTIC	O	O
LEFT	O	O
RENAL	O	O
VEIN	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
RETROPERITONEAL	O	O
LYMPHADENOPATHY	O	O
.	O	O
THE	O	O
PATIENT	O	O
IS	O	O
STATUS	O	3_Yellow_Days
POST	O	3_Yellow_Days
HYSTERECTOMY	O	3_Yellow_Days
.	O	O
SMALL	3_Yellow_Days	O
AMOUNT	3_Yellow_Days	O
OF	3_Yellow_Days	O
FREE	3_Yellow_Days	O
FLUID	3_Yellow_Days	O
IS	3_Yellow_Days	O
NOTED	3_Yellow_Days	O
WITHIN	3_Yellow_Days	O
THE	3_Yellow_Days	O
PELVIS	3_Yellow_Days	O
.	O	O
THIS	3_Yellow_Days	O
IS	3_Yellow_Days	O
NEW	3_Yellow_Days	O
IN	O	O
COMPARISON	O	O
TO	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
NO	O	O
ANEURYSMAL	O	O
DILATATION	O	O
OF	O	O
THE	O	O
ABDOMINAL	O	O
AORTA	O	O
IS	O	O
SEEN	O	O
.	O	O
DELAYED	O	O
IMAGING	O	O
THROUGH	O	O
THE	O	O
URINARY	O	O
BLADDER	O	O
DEMONSTRATES	O	O
NO	O	O
OBVIOUS	O	O
FILLING	O	O
DEFECTS	O	O
.	O	O
EVALUATION	O	O
OF	O	O
THE	O	O
BONY	O	O
WINDOWS	O	O
DEMONSTRATES	O	O
MULTILEVEL	O	3_Yellow_Days
DEGENERATIVE	O	3_Yellow_Days
DISC	O	3_Yellow_Days
DISEASE	O	3_Yellow_Days
.	O	O
A	O	O
NEW	O	3_Yellow_Days
SMALL	O	3_Yellow_Days
RIGHT	O	3_Yellow_Days
PLEURAL	O	3_Yellow_Days
EFFUSION	O	3_Yellow_Days
IS	O	3_Yellow_Days
SEEN	O	O
.	O	O
1	O	O
.	O	O
SLIGHT	1_Red_Minutes	3_Yellow_Days
INTERVAL	1_Red_Minutes	3_Yellow_Days
DECREASE	1_Red_Minutes	3_Yellow_Days
IN	1_Red_Minutes	3_Yellow_Days
SIZE	1_Red_Minutes	3_Yellow_Days
IN	1_Red_Minutes	3_Yellow_Days
AN	1_Red_Minutes	3_Yellow_Days
ANTERIOR	1_Red_Minutes	3_Yellow_Days
SEGMENT	1_Red_Minutes	1_Red_Minutes
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
MASS	1_Red_Minutes	1_Red_Minutes
,	O	1_Red_Minutes
NOW	O	1_Red_Minutes
MEASURING	O	1_Red_Minutes
3.6	O	1_Red_Minutes
CM	O	1_Red_Minutes
X	O	1_Red_Minutes
2.2	O	1_Red_Minutes
CM	O	1_Red_Minutes
IN	O	1_Red_Minutes
COMPARISON	O	1_Red_Minutes
TO	O	1_Red_Minutes
3.9	O	1_Red_Minutes
CM	O	1_Red_Minutes
X	O	1_Red_Minutes
2.6	O	3_Yellow_Days
CM	O	3_Yellow_Days
IN	O	3_Yellow_Days
SIZE	O	3_Yellow_Days
.	O	O
THERE	O	O
HAS	O	O
BEEN	O	O
INTERVAL	1_Red_Minutes	O
DEVELOPMENT	1_Red_Minutes	O
OF	1_Red_Minutes	O
CENTRAL	1_Red_Minutes	O
NECROSIS	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
ADJACENT	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
TO	3_Yellow_Days	O
THIS	3_Yellow_Days	O
REGION	3_Yellow_Days	O
.	O	O
2	O	O
.	O	O
NO	3_Yellow_Days	O
SIGNIFICANT	3_Yellow_Days	O
INTERVAL	3_Yellow_Days	O
CHANGE	3_Yellow_Days	O
IN	3_Yellow_Days	O
SMALL	3_Yellow_Days	O
5	3_Yellow_Days	O
MM	3_Yellow_Days	O
NODULAR	3_Yellow_Days	O
LESION	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
LEFT	3_Yellow_Days	O
APEX	3_Yellow_Days	O
.	O	O
NO	O	O
NEW	O	O
NODULES	O	O
ARE	O	O
IDENTIFIED	O	O
.	O	O
3	O	O
.	O	O
NEW	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
.	O	O
4	O	O
.	O	O
NO	O	O
SIGNIFICANT	O	O
INTERVAL	O	O
CHANGE	O	O
IN	O	O
SEGMENT	3_Yellow_Days	O
2	3_Yellow_Days	O
AND	3_Yellow_Days	O
3	3_Yellow_Days	O
HEPATIC	3_Yellow_Days	O
CYSTS	3_Yellow_Days	O
.	O	O
5	O	O
.	O	O
INTERVAL	3_Yellow_Days	O
DEVELOPMENT	3_Yellow_Days	O
OF	3_Yellow_Days	O
A	3_Yellow_Days	O
SMALL	3_Yellow_Days	1_Red_Minutes
AMOUNT	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
FREE	3_Yellow_Days	1_Red_Minutes
FLUID	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
PELVIS	3_Yellow_Days	1_Red_Minutes
,	O	1_Red_Minutes
CLINICAL	3_Yellow_Days	1_Red_Minutes
CORRELATION	3_Yellow_Days	1_Red_Minutes
RECOMMENDED	3_Yellow_Days	1_Red_Minutes
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
36761427	O	O
FULL	O	O
RESULT	O	O
:	O	O
Examination	O	O
:	O	O
CT	O	O
Thorax	O	O
with	O	O
Contrast	O	O
,	O	O
10/26/2007	O	O
Clinical	O	O
History	O	O
:	O	O
History	O	O
of	O	O
bronchoalveolar	O	O
carcinoma	O	O
,	O	O
evaluation	O	O
.	O	O
Comparison	O	O
:	O	O
Chest	O	O
CT	O	O
04/06/2007	O	O
and	O	O
09/25/2006	O	O
.	O	O
Technique	O	O
:	O	O
Spiral	O	O
CT	O	O
images	O	O
of	O	O
the	O	O
chest	O	O
were	O	O
performed	O	O
from	O	O
the	O	O
lung	O	O
apices	O	O
to	O	O
the	O	O
level	O	O
of	O	O
the	O	O
adrenal	O	O
glands	O	O
.	O	O
After	O	O
the	O	O
administration	O	O
of	O	O
contrast	O	O
,	O	O
2.5	O	O
mm	O	O
axial	O	O
images	O	O
were	O	O
obtained	O	O
and	O	O
reformatted	O	O
in	O	O
sagittal	O	O
and	O	O
coronal	O	O
planes	O	O
.	O	O
Findings	O	O
:	O	O
When	O	O
compared	O	O
to	O	O
the	O	O
previous	O	O
exam	O	O
there	O	O
has	O	O
been	O	O
no	3_Yellow_Days	O
interval	3_Yellow_Days	O
change	3_Yellow_Days	O
in	3_Yellow_Days	O
the	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
,	3_Yellow_Days	O
multifocal	3_Yellow_Days	O
ground-glass	3_Yellow_Days	O
opacities	3_Yellow_Days	O
consistent	3_Yellow_Days	O
with	3_Yellow_Days	O
biopsy	3_Yellow_Days	O
proven	3_Yellow_Days	O
,	3_Yellow_Days	O
well	3_Yellow_Days	O
differentiated	3_Yellow_Days	O
bronchoalveolar	3_Yellow_Days	O
carcinoma	3_Yellow_Days	O
.	O	O
No	O	O
new	O	O
lesions	O	O
are	O	O
seen	O	O
.	O	O
There	O	O
are	O	O
no	O	O
new	O	O
nodules	O	O
,	O	O
masses	O	O
,	O	O
consolidation	O	O
or	O	O
effusion	O	O
.	O	O
The	O	O
trachea	O	O
and	O	O
major	O	O
bronchi	O	O
are	O	O
normal	O	O
,	O	O
without	O	O
endobronchial	O	O
lesions	O	O
.	O	O
The	O	O
pulmonary	O	O
vascular	O	O
structures	O	O
show	O	O
no	O	O
filling	O	O
defects	O	O
.	O	O
There	O	O
is	O	O
no	O	O
mediastinal	O	O
,	O	O
hilar	O	O
,	O	O
axillary	O	O
or	O	O
supraclavicular	O	O
lymphadenopathy	O	O
.	O	O
No	O	O
destructive	O	O
bone	O	O
lesions	O	O
are	O	O
noted	O	O
.	O	O
There	O	O
is	O	O
a	O	O
small	O	O
hiatal	O	O
hernia	O	O
.	O	O
Bilateral	O	O
adrenal	O	O
glands	O	O
are	O	O
normal	O	O
.	O	O
The	O	O
rest	O	O
of	O	O
the	O	O
abdomen	O	O
is	O	O
unremarkable	O	O
.	O	O
IMPRESSION	O	O
:	O	O
Stable	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
multifocal	3_Yellow_Days	O
ground-glass	3_Yellow_Days	O
opacities	3_Yellow_Days	O
consistent	3_Yellow_Days	O
with	3_Yellow_Days	O
bronchioalveolar	3_Yellow_Days	O
carcinoma	3_Yellow_Days	O
.	O	O
CT	O	O
CT	O	O
,	O	O
LUNG	O	O
,	O	O
MED	O	O
,	O	O
PLEURA	O	O
W/CONTRAST	O	O
07213	O	O
CT	O	O
CHEST	O	O
wo	O	O
Lmtd	O	O
CT05/07/2007	O	O
ES	O	O
>	O	O
<	O	O
REPOCT	O	O
of	O	O
the	O	O
abdomen	O	O
without	O	O
contrast	O	O
done	O	O
according	O	O
to	O	O
the	O	O
renal	O	O
stone	O	O
quantification	O	O
protocol	O	O
,	O	O
including	O	O
coronal	O	O
reformatted	O	O
images	O	O
of	O	O
the	O	O
kidneys	O	O
shows	O	O
no	O	O
change	O	O
since	O	O
2-2-06	O	O
in	O	O
the	O	O
small	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
renal	3_Yellow_Days	O
calculi	3_Yellow_Days	O
.	O	O
Renal	O	O
stone	O	O
quantification	O	O
evaluation	O	O
pending	O	O
validation	O	O
.	O	O
Initial	O	O
estimate	O	O
includes	O	O
:	O	O
Right	O	O
kidney	O	O
-LRB-	O	O
A/V	O	O
-RRB-	O	O
36/36	O	O
;	O	O
left	O	O
,	O	O
90/82	O	O
.	O	O
No	O	O
urinary	O	O
calculi	O	O
.	O	O
Cholecystectomy	O	O
.	O	O
Slight	O	3_Yellow_Days
aortic	O	3_Yellow_Days
calcification	O	3_Yellow_Days
.	O	O

